Contraceptive Development Research Center (P50 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary approaches towards the development of new and/or improved contraceptive methods for both men and women through the formation of a Contraceptive Development Research Center. This FOA also allows the inclusion of translational studies to facilitate the pre-clinical to clinical transition and increase the likelihood of clinical success. The Center will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.


  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s): December 1, 2022

RFA-HD-23-029 Expiration Date December 02, 2022

Agency Website

Amount Description

Each Center should propose a budget that reflects the actual needs of the proposed projects and costs; the budget must not exceed $1.3 million per year in direct costs, excluding third party F&A.

The scope of the proposed project should determine the project period. The maximum period of performance is 3 years.

    Funding Type





    Medical - Basic Science
    Medical - Clinical Science
    Medical - Translational

    External Deadline

    December 1, 2022